Skip to main content
Clinical Trials/KCT0004871
KCT0004871
Not yet recruiting
未知

The comparative study of symptom improvement according to proton pump inhibitor therapy approaches in laryngopharyngeal reflux disease patient

Hallym University Medical Center-Dongtan0 sites72 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Diseases of th respiratory system
Sponsor
Hallym University Medical Center-Dongtan
Enrollment
72
Status
Not yet recruiting
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
6 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Hallym University Medical Center-Dongtan

Eligibility Criteria

Inclusion Criteria

  • (1\) Patients over 18 year
  • (2\) Those with above 13 and 7 score in reflux symptom index and reflux finding score and have laryngopharyngeal reflux disease in larynx endoscope
  • (3\) Patients who agree to participate in this study voluntarily

Exclusion Criteria

  • (1\) The highly sensitive person to proton pump inhibitor
  • (2\) Those with the malignant tumor or infection of the larynx
  • (3\) Those with need to take steroids or aspirin (more than 325mg/d), warfarin, coumarin during this study constantly
  • (4\) Those who has undergone surgery or treatment for gastroesophageal reflux disease
  • (5\) Those who has undergone gastric acid suppression surgery or gastro\-duodenal surgery
  • (6\) Those who has undergone major surgery affecting gastric acid secretion
  • (7\) Those with the history of administration with other proton pump inhibitor or H2\-blocker within 3 months
  • (8\) Psychiatric patient, alcohol addictor or those with the history of drug abuse
  • (9\) Pregnant and lactating women
  • (10\) Childbearing women (Menopausal women who are amenorrheic for at least 12 months are considered to be non\-childbearing women.)

Outcomes

Primary Outcomes

Not specified

Similar Trials